Treosulfan-induced myalgia in pediatric hematopoietic stem cell transplantation identified by an electronic health record text mining tool

Treosulfan-induced myalgia in pediatric hematopoietic stem cell transplantation identified by an electronic health record text mining tool

Abstract Treosulfan is increasingly used as myeloablative agent in conditioning regimen prior to allogeneic hematopoietic stem cell transplantation (HSCT). In our pediatric HSCT program, myalgia was regularly observed after treosulfan-based conditioning, which is a relatively unknown side effect. Us...

Full description

Bibliographic Details
Main Authors: M. Y. Eileen C. van der Stoep, Dagmar Berghuis, Robbert G. M. Bredius, Emilie P. Buddingh, Alexander B. Mohseny, Frans J. W. Smiers, Henk-Jan Guchelaar, Arjan C. Lankester, Juliette Zwaveling
Format: Article
Language:English
Published: Nature Publishing Group 2021-09-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-98669-3

Internet

https://doi.org/10.1038/s41598-021-98669-3

Similar Items